Verition Fund Management’s Artelo Biosciences, Inc. Warrant ARTLW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-27,299
| Closed | -$440 | – | 3363 |
|
|
2024
Q1 | $440 | Hold |
27,299
| – | – | ﹤0.01% | 2742 |
|
|
2023
Q4 | $1.09K | Hold |
27,299
| – | – | ﹤0.01% | 2279 |
|
|
2023
Q3 | $1.32K | Hold |
27,299
| – | – | ﹤0.01% | 2293 |
|
|
2023
Q2 | $2.21K | Hold |
27,299
| – | – | ﹤0.01% | 2146 |
|
|
2023
Q1 | $1.78K | Hold |
27,299
| – | – | ﹤0.01% | 2107 |
|
|
2022
Q4 | $1.09K | Sell |
27,299
-7,701
| -22% | -$641 | ﹤0.01% | 2040 |
|
|
2022
Q3 | $4K | Hold |
35,000
| – | – | ﹤0.01% | 2952 |
|
|
2022
Q2 | $166K | Hold |
35,000
| – | – | ﹤0.01% | 1990 |
|
|
2022
Q1 | $6K | Hold |
35,000
| – | – | ﹤0.01% | 2659 |
|
|
2021
Q4 | $6K | Hold |
35,000
| – | – | ﹤0.01% | 2497 |
|
|
2021
Q3 | $8K | Hold |
35,000
| – | – | ﹤0.01% | 1840 |
|
|
2021
Q2 | $11K | Hold |
35,000
| – | – | ﹤0.01% | 1843 |
|
|
2021
Q1 | $15K | Hold |
35,000
| – | – | ﹤0.01% | 1506 |
|
|
2020
Q4 | $9K | Hold |
35,000
| – | – | ﹤0.01% | 1056 |
|
|
2020
Q3 | $3K | Hold |
35,000
| – | – | ﹤0.01% | 1026 |
|
|
2020
Q2 | $4K | Hold |
35,000
| – | – | ﹤0.01% | 1036 |
|
|
2020
Q1 | $2K | Hold |
35,000
| – | – | ﹤0.01% | 561 |
|
|
2019
Q4 | $10K | Hold |
35,000
| – | – | ﹤0.01% | 1032 |
|
|
2019
Q3 | $20K | Hold |
35,000
| – | – | ﹤0.01% | 1005 |
|
|
2019
Q2 | $30K | Buy |
+35,000
| New | +$30.5K | ﹤0.01% | 1023 |
|
Verition Fund Management's ARTLW Position: Q2 2024 in Review
Verition Fund Management sold out of Artelo Biosciences, Inc. Warrant (ARTLW) in Q2 2024, closing a stake of 27,299 shares — an estimated $440 sold.
Verition Fund Management first reported a position in ARTLW in Q2 2019 and held it in 20 quarters. The position peaked at $166K in Q2 2022. 0 funds tracked by Wall St. Rank hold ARTLW as of Q2 2024.
- Verition Fund Management reported no remaining Artelo Biosciences, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
- Verition Fund Management sold 27,299 Artelo Biosciences, Inc. Warrant shares in Q2 2024, an estimated $440.
- Verition Fund Management first reported a position in Artelo Biosciences, Inc. Warrant in Q2 2019 and held it in 20 quarters.
- Verition Fund Management's Artelo Biosciences, Inc. Warrant position peaked at $166K in Q2 2022.
- 0 funds tracked by Wall St. Rank held Artelo Biosciences, Inc. Warrant as of Q2 2024.
Based on Verition Fund Management's 13F filing for Q2 2024, filed 14 Aug 2024.